$NGNE·4

AQUINOX PHARMACEUTICALS, INC · Mar 10, 5:27 PM ET

AQUINOX PHARMACEUTICALS, INC 4

4 · AQUINOX PHARMACEUTICALS, INC · Filed Mar 10, 2014

Insider Transaction Report

Form 4
Period: 2014-03-06
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-03-06+8,33320,051 total
    Exercise: $11.00Exp: 2024-03-05Common Stock (8,333 underlying)
Footnotes (2)
  • [F1]The shares subject to this option shall vest in equal annual installments, at a rate of 1/3rd of the total number of shares on the one-year anniversary of the grant date, 1/3rd of the total number of shares on the second-year anniversary of the grant date, and 1/3rd of the total number of shares on the third-year anniversary of the grant date.
  • [F2]Includes (i) 8,333 shares issuable upon exercise of an option grant pursuant to the issuer's 2014 Equity Incentive Plan (the "2014 Plan") and (ii) 11,718 option securities issuable upon exercise of an option granted pursuant to the issuer's Joint Canadian Stock Option Plan (the "2006 Plan"). Each option under the 2014 Plan is exercisable for shares of common stock. Each option security granted under the 2006 Plan is exercisable for an "option security". Prior to the closing of the issuer's initial public offering, an option security is comprised of one common exchangeable share and one special voting share of Aquinox Pharmaceuticals Inc., a corporation under the Canadian Business Corporations Act. Following the closing of the issuer's initial public offering, an option security will be comprised of one share of the issuer's common stock.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION